Myriad Genetics (MYGN) Stock Trades Up, Here Is Why [Yahoo! Finance]
Myriad Genetics, Inc. (MYGN)
Last myriad genetics, inc. earnings: 2/6 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
myriad.com/news-center/investor-information
Company Research
Source: Yahoo! Finance
announced the launch of its Precise MRD™ test for breast cancer patients and presented at a healthcare conference. The new test, which detects what is known as molecular residual disease, was designed to help doctors monitor patients during cancer treatment. Myriad Genetics initiated the launch with a select number of oncology practices, with plans for a broader commercial rollout across the U.S. later in the year. The development came as the company also presented at the TD Cowen 46th Annual Health Care Conference. This news followed a recent earnings call in which the company reaffirmed its full-year 2026 financial outlook, signaling confidence in its growth. After the initial pop the shares cooled down to $5.26, up 4.9% from previous close. Is now the time to buy Myriad Genetics? Access our full analysis report here, it's free What Is The Market Telling Us Myriad Genetics's shares are extremely volatile and have had 45 moves greater than 5% over the last year. In that con
Show less
Read more
Impact Snapshot
Event Time:
MYGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MYGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MYGN alerts
High impacting Myriad Genetics, Inc. news events
Weekly update
A roundup of the hottest topics
MYGN
News
- Myriad Commercially Launches Precise MRD with Select Community Oncologists [Yahoo! Finance]Yahoo! Finance
- Myriad Commercially Launches Precise MRD with Select Community OncologistsGlobeNewswire
- Myriad Genetics (MYGN) was upgraded by Zacks Research from "strong sell" to "hold".MarketBeat
- Why Myriad Genetics (MYGN) Stock Is Trading Up Today [Yahoo! Finance]Yahoo! Finance
- Myriad Genetics (NASDAQ:MYGN) had its price target lowered by analysts at Wells Fargo & Company from $6.50 to $6.00. They now have an "equal weight" rating on the stock.MarketBeat
MYGN
Earnings
- 2/23/26 - Beat
MYGN
Sec Filings
- 3/5/26 - Form EFFECT
- 3/4/26 - Form 424B3
- 3/2/26 - Form 4
- MYGN's page on the SEC website